BioCryst Pharmaceuticals
BCRX
BCRX
154 hedge funds and large institutions have $427M invested in BioCryst Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 43 reducing their positions, and 35 closing their positions.
Holders
154
Holders Change
-11
Holders Change %
-6.67%
% of All Funds
3.12%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
25
Increased
62
Reduced
43
Closed
35
Calls
$4.4M
Puts
$4.64M
Net Calls
-$237K
Net Calls Change
-$8.12M
Top Buyers
1 |
SCM
1
Sarissa Capital Management
Greenwich,
Connecticut
|
$16.7M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$4.94M |
3 |
3
BlackRock
New York
|
$54.8M |
4 |
4
Victory Capital Management
San Antonio,
Texas
|
$4.11M |
5 |
5
State Street
Boston,
Massachusetts
|
$55.6M |